CN114522196A - Compound traditional Chinese medicine for preventing and treating osteoporosis and preparation method thereof - Google Patents
Compound traditional Chinese medicine for preventing and treating osteoporosis and preparation method thereof Download PDFInfo
- Publication number
- CN114522196A CN114522196A CN202210071537.1A CN202210071537A CN114522196A CN 114522196 A CN114522196 A CN 114522196A CN 202210071537 A CN202210071537 A CN 202210071537A CN 114522196 A CN114522196 A CN 114522196A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- preventing
- compound traditional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000001132 Osteoporosis Diseases 0.000 title claims abstract description 71
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 150000001875 compounds Chemical class 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 210000002826 placenta Anatomy 0.000 claims abstract description 34
- 239000002994 raw material Substances 0.000 claims abstract description 33
- 241000220317 Rosa Species 0.000 claims abstract description 24
- 241000893536 Epimedium Species 0.000 claims abstract description 20
- 239000010975 amethyst Substances 0.000 claims abstract description 20
- 235000018905 epimedium Nutrition 0.000 claims abstract description 20
- 241001116742 Drynaria Species 0.000 claims abstract description 19
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 19
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 19
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 19
- 241000972672 Phellodendron Species 0.000 claims abstract description 19
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 19
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 19
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 14
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 12
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 12
- 244000061520 Angelica archangelica Species 0.000 claims abstract 5
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 5
- 244000294611 Punica granatum Species 0.000 claims abstract 5
- 241000237502 Ostreidae Species 0.000 claims description 52
- 235000020636 oyster Nutrition 0.000 claims description 52
- 239000000052 vinegar Substances 0.000 claims description 35
- 235000021419 vinegar Nutrition 0.000 claims description 35
- 239000002245 particle Substances 0.000 claims description 32
- 241000209094 Oryza Species 0.000 claims description 28
- 235000007164 Oryza sativa Nutrition 0.000 claims description 28
- 239000000706 filtrate Substances 0.000 claims description 28
- 235000009566 rice Nutrition 0.000 claims description 28
- 238000002791 soaking Methods 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 241000245665 Taraxacum Species 0.000 claims description 18
- 238000001035 drying Methods 0.000 claims description 16
- 241000283690 Bos taurus Species 0.000 claims description 14
- 229920001353 Dextrin Polymers 0.000 claims description 14
- 239000004375 Dextrin Substances 0.000 claims description 14
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 14
- 229930006000 Sucrose Natural products 0.000 claims description 14
- 235000019425 dextrin Nutrition 0.000 claims description 14
- 238000007873 sieving Methods 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 229960004793 sucrose Drugs 0.000 claims description 14
- 239000005720 sucrose Substances 0.000 claims description 12
- 241001116477 Adenophora triphylla Species 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 8
- 235000011449 Rosa Nutrition 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 235000021329 brown rice Nutrition 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 235000000661 Rosa laevigata Nutrition 0.000 claims 2
- 241001278833 Rosa laevigata Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 19
- 208000024891 symptom Diseases 0.000 abstract description 19
- 210000000988 bone and bone Anatomy 0.000 abstract description 12
- 210000003734 kidney Anatomy 0.000 abstract description 9
- 238000005728 strengthening Methods 0.000 abstract description 7
- 201000000736 Amenorrhea Diseases 0.000 abstract description 6
- 206010001928 Amenorrhoea Diseases 0.000 abstract description 6
- 231100000540 amenorrhea Toxicity 0.000 abstract description 6
- 210000003205 muscle Anatomy 0.000 abstract description 5
- 229940011871 estrogen Drugs 0.000 abstract description 3
- 239000000262 estrogen Substances 0.000 abstract description 3
- 230000003750 conditioning effect Effects 0.000 abstract description 2
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 241000125175 Angelica Species 0.000 description 14
- 241000219991 Lythraceae Species 0.000 description 14
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 241001106477 Paeoniaceae Species 0.000 description 9
- 208000001685 postmenopausal osteoporosis Diseases 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 7
- 241000736199 Paeonia Species 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000009245 menopause Effects 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 241001270131 Agaricus moelleri Species 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010030247 Oestrogen deficiency Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000243684 Lumbricus Species 0.000 description 1
- 206010057178 Osteoarthropathies Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 241001038562 Pseudostellaria heterophylla Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 235000021178 picnic Nutrition 0.000 description 1
- 206010036601 premature menopause Diseases 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Developmental Biology & Embryology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a compound traditional Chinese medicine for preventing and treating osteoporosis and a preparation method thereof, wherein the formula comprises the following raw materials in parts by weight: 4 to 10 parts of drynaria rhizome, 3 to 6 parts of human placenta, 0.06 to 0.12 part of earthworm, 2 to 5.5 parts of bitter rose, 1.3 to 3.8 parts of calcined oyster shell, 2.5 to 6.5 parts of pomegranate bark, 2.5 to 6.5 parts of radix pseudostellariae, 4 to 12 parts of angelica, 1.2 to 3.6 parts of phellodendron, 0.2 to 0.55 part of amethyst, 0.4 to 1.2 parts of kudzu root, 0.3 to 1.5 parts of red paeony root, 4 to 8.5 parts of epimedium herb and 2 to 6.5 parts of dandelion root. The compound traditional Chinese medicine for preventing and treating osteoporosis takes the measures of tonifying kidney yang, strengthening bones and muscles and conditioning estrogen, and can play a role in treating and preventing osteoporosis symptoms, particularly osteoporosis symptoms caused by female amenorrhea, by adjusting the mutual matching of the traditional Chinese medicine raw materials, and the effect is most obvious.
Description
Technical Field
The invention relates to the technical field of food preparation, in particular to a compound traditional Chinese medicine for preventing and treating osteoporosis and a preparation method thereof.
Background
Osteoporosis can result from a decrease in bone density and quality, destruction of bone microarchitecture, etc., due to a variety of causes. Osteoporosis includes both primary and secondary categories, with postmenopausal osteoporosis (PMO) being the most common form of primary osteoporosis. Postmenopausal osteoporosis (PMO) is a common disease related to aging, mainly occurs in postmenopausal women, due to the fact that estrogen deficiency causes reduction of bone mass and structural change of bone tissues, bone fragility is increased, fracture is easy, pain, bone deformation, complications and the like caused by fracture seriously affect the health and life quality of old people, and even shorten life.
Postmenopausal osteoporosis (PMO) is mainly caused by estrogen deficiency, occurs in female patients, and is involved in multiple factors such as heredity, life style and nutrition. Family history of osteoporosis, women with special genes affecting bone mass, insufficient calcium intake, lack of physical activity, massive smoking and drinking, early menopause and the like are all high-risk factors. Therefore, for the treatment of this type of diseases, in particular prevention, is of particular importance.
Chinese patent CN104161936A discloses a traditional Chinese medicine composition for preventing and/or treating postmenopausal osteoporosis, which is prepared from the following medicinal materials in parts by weight: 28-31 parts of fructus psoraleae, 27-32 parts of semen cuscutae, 26-32 parts of rhizoma drynariae, 24-26 parts of fructus lycii, 21-25 parts of donkey-hide gelatin, 22-25 parts of raspberry, 22-26 parts of rhizoma cyperi, 23-25 parts of salvia miltiorrhiza and 22-24 parts of radix achyranthis bidentatae. However, the traditional Chinese medicine composition for preventing and/or treating postmenopausal osteoporosis prepared by the patent has poor health-care and prevention effects.
Disclosure of Invention
In view of the above, the present invention provides a compound traditional Chinese medicine for preventing and treating osteoporosis and a preparation method thereof, so as to solve the above technical problems.
The invention provides the following technical scheme: the formula of the compound traditional Chinese medicine for preventing and treating the osteoporosis comprises the following raw materials in parts by weight: 4 to 10 parts of drynaria rhizome, 3 to 6 parts of human placenta, 0.06 to 0.12 part of earthworm, 2 to 5.5 parts of bitter rose, 1.3 to 3.8 parts of calcined oyster shell, 2.5 to 6.5 parts of pomegranate bark, 2.5 to 6.5 parts of radix pseudostellariae, 4 to 12 parts of angelica, 1.2 to 3.6 parts of phellodendron, 0.2 to 0.55 part of amethyst, 0.4 to 1.2 parts of kudzu root, 0.3 to 1.5 parts of red paeony root, 4 to 8.5 parts of epimedium herb and 2 to 6.5 parts of dandelion root.
Further, the formula of the compound traditional Chinese medicine for preventing and treating osteoporosis comprises the following raw materials in parts by weight: 5 to 8 parts of drynaria rhizome, 4.5 to 5.5 parts of human placenta, 0.08 to 0.10 part of earthworm, 3 to 4.5 parts of bitter rose, 2.0 to 3.0 parts of calcined oyster, 3.5 to 5.5 parts of pomegranate peel, 3.5 to 5.5 parts of rhizoma gastrodiae, 6 to 10 parts of angelica, 1.8 to 3.0 parts of phellodendron, 0.35 to 0.45 part of amethyst, 0.6 to 1.0 part of kudzu root, 0.5 to 1.2 parts of red paeony root, 5.5 to 7.0 parts of epimedium herb and 3.5 to 5.0 parts of dandelion root.
Further, the formula of the compound traditional Chinese medicine for preventing and treating osteoporosis comprises the following raw materials in parts by weight: 7 parts of drynaria rhizome, 4.5 parts of human placenta, 0.09 part of earthworm, 3.5 parts of bitter rose, 2.5 parts of calcined oyster shell, 4.5 parts of pomegranate rind, 4.5 parts of radix pseudostellariae, 8 parts of angelica, 2.4 parts of phellodendron, 0.35 part of amethyst, 0.8 part of kudzu root, 0.9 part of red peony root, 6.0 parts of epimedium herb and 4.2 parts of dandelion root.
In the traditional Chinese medicine, the 'kidney generates bone marrow', the marrow is biochemically active when the kidney essence is sufficient, and the bone is nourished and strong, so that the prescription for preventing and treating osteoporosis not only has the effect of directly strengthening the bone, but also simultaneously performs the function of tonifying the kidney, and for the postmenopausal osteoporosis of women, the secretion and improvement of female hormone are considered. The rhizoma drynariae in the raw materials has the effects of tonifying kidney, strengthening bone, healing wound and relieving pain, and has good relieving effects on preventing and treating symptoms of the osteoporosis and symptoms of tinnitus, deafness, kidney deficiency, lumbago and the like caused by the osteoporosis; the placenta hominis has the effects of benefiting qi, nourishing blood and replenishing vital essence, and can also be used for generating estrogen and progestogen for several times to relieve or delay osteoporosis symptoms caused by hormone level; lumbricus has effects of dredging meridian passage, promoting blood circulation, and removing blood stasis, and can be used with radix Angelicae sinensis for treating qi deficiency and blood stagnation; the rose has the effects of promoting qi circulation, relieving depression, regulating blood circulation and relieving pain, can regulate the female hormone level, damage blood stasis and other symptoms, is particularly suitable for regulating women before and after menopause, soothing the liver, regulating qi and relieving mood fluctuation; the oyster is mainly calcium carbonate and calcium phosphate, and the calcined oyster has the effects of astringing, arresting discharge and removing acidity, can also relieve symptoms such as uneasiness, insomnia, liver-yang hyperactivity and the like, and can be used together with the pseudostellaria heterophylla to strengthen the effects of arresting sweating, consolidating exterior, strengthening spleen and replenishing qi; the pericarpium Granati has effects of relieving diarrhea with astringents, and expelling parasite; radix Angelicae sinensis has effects of replenishing blood, promoting blood circulation, regulating menstruation, relieving pain, and loosening bowel to relieve constipation, and can be used for treating rheumatalgia and traumatic injury; cortex Phellodendri is mainly used for treating damp-heat dysentery, leukorrhagia pruritus vulvae, hectic fever due to yin-deficiency, night sweat, etc., and radix Angelicae sinensis and cortex Phellodendri can be used together for replenishing blood, promoting blood circulation, and reducing night sweat symptoms; the amethyst has the effects of relieving palpitation, tranquilizing, lowering adverse qi, warming uterus, nourishing blood, eliminating dampness, treating asthenia, palpitation, and kidney-yang deficiency, and can promote ovary secretion and regulate hormone level; radix Puerariae has effects of expelling pathogenic factors from muscles, relieving fever, promoting fluid production to quench thirst, invigorating yang, and relieving diarrhea; radix Paeoniae Rubra has effects of clearing heat and cooling blood, promoting blood circulation and removing blood stasis, and can be used for treating amenorrhea due to blood stagnation when combined with radix Angelicae sinensis; the epimedium has the functions of tonifying kidney yang, strengthening muscles and bones and dispelling wind-damp, can tonify kidney yang, relieve osteoporosis caused by amenorrhea, relieve rheumatic osteoarthropathy symptoms and reduce body discomfort caused by osteoporosis; the herba Taraxaci has effects of clearing heat and detoxicating, promoting diuresis and resolving hard mass, nourishing yin and cooling blood, relaxing muscles and tendons and strengthening teeth.
Furthermore, the bitter rose is dried bitter rose with water content of 4-10 wt% in Yongdeng county in Gansu province. The picnic rose from Yongdeng county in Gansu province is a rare plateau selenium-rich rose variety in the world, and has high selenium content and strong antioxidant function.
Further, the preparation method of the calcined oyster comprises the following steps: cleaning 100 parts of raw oyster shells, soaking in 80-120 parts of rice vinegar at 25-40 ℃ for 10-20 hours, boiling to remove the rice vinegar, drying in an oven at 320-400 ℃ for 50-70 minutes, and crushing to obtain calcined oysters.
Further, the rice vinegar is selected from brown rice vinegar, glutinous rice vinegar, fruit vinegar, and white rice vinegar.
Furthermore, the particle size of the calcined oyster obtained by the grinding is less than or equal to 1500 meshes.
The invention also aims to provide a preparation method of the compound traditional Chinese medicine for preventing and treating osteoporosis, which comprises the following steps:
(1) crushing the drynaria rhizome, the earthworm, the rosa amara, the pomegranate rind, the adenophora tetraphylla, the angelica, the phellodendron, the amethyst, the radix puerariae, the red paeony root, the epimedium herb and the dandelion root in parts by weight, and sieving the crushed materials by a 40-mesh sieve to obtain raw material particles with the particle size of less than 40 meshes;
(2) putting the raw material particles obtained in the step (1) into water of which the weight is 3-7 times that of the raw material particles, soaking for 1 hour, decocting for 1.5-3 hours to obtain primary filtrate and filter residue, adding water of which the weight is 2-4 times that of the filter residue, soaking for 1-2 hours to obtain secondary filtrate, combining the primary filtrate and the secondary filtrate, and concentrating under reduced pressure to obtain an extract with the relative density of 1.15-1.3;
(3) crushing the calcined oyster and the human placenta in parts by weight, sieving the crushed oyster and the human placenta with a 100-mesh sieve, sterilizing, adding the crushed oyster and the human placenta into the extract obtained in the step (2), and uniformly stirring and mixing to obtain a mixed paste;
(4) and (4) adding auxiliary dextrin and cane sugar into the mixed paste obtained in the step (3), uniformly stirring, granulating, and drying to obtain the compound traditional Chinese medicine for preventing and treating osteoporosis.
Further, in the step (4), the adding weight ratio of the mixed paste, the auxiliary dextrin and the sucrose is 10: 2-3.5: 1.0-2.
According to the technical scheme, the invention has the beneficial effects that:
(1) the compound traditional Chinese medicine for preventing and treating osteoporosis takes the measures of tonifying kidney yang, strengthening bones and muscles and conditioning estrogen, and regulates the medicine property and effect among the medicines by adjusting the mutual matching among the traditional Chinese medicine raw materials, so that the compound traditional Chinese medicine can treat and prevent osteoporosis symptoms, particularly osteoporosis symptoms caused by female amenorrhea, and has the most obvious effect.
(2) The compound traditional Chinese medicine for preventing and treating osteoporosis prepared by the invention can effectively relieve osteoporosis caused by menopause, and symptoms such as waist and back pain, soreness and weakness of feet and knees, frequent nocturia, spontaneous night sweat, dizziness and tinnitus and the like caused by the osteoporosis, the effective rate of treatment can reach more than 90%, the osteoporosis can be effectively prevented and stopped, the preparation method is simple, the preparation process is operated, and the compound traditional Chinese medicine is suitable for large-scale production.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail with reference to the following embodiments. The exemplary embodiments and descriptions of the present invention are provided to explain the present invention, but not to limit the present invention.
Example 1
Compound traditional Chinese medicine for preventing and treating osteoporosis and preparation method thereof
The formula of the compound traditional Chinese medicine for preventing and treating the osteoporosis comprises the following raw materials in parts by weight: 4 parts of drynaria rhizome, 3 parts of human placenta, 0.06 part of earthworm, 2 parts of bitter rose, 1.3 parts of calcined oyster shell, 2.5 parts of pomegranate rind, 2.5 parts of adenophora tetraphylla, 4 parts of angelica, 1.2 parts of phellodendron, 0.2 part of amethyst, 0.4 part of kudzu root, 0.3 part of red peony root, 4 parts of epimedium and 2 parts of dandelion root; the preparation method of the calcined oyster comprises the following steps: cleaning 100 parts of raw oyster shells, soaking in 80 parts of rice vinegar at 25 ℃ for 10 hours, boiling to remove the rice vinegar, drying in a drying oven at 320 ℃ for 50 minutes, and crushing to obtain calcined oysters with the particle size of less than or equal to 1500 meshes; the rice vinegar is brown rice vinegar.
The preparation method of the compound traditional Chinese medicine for preventing and treating osteoporosis comprises the following steps:
(1) crushing the drynaria rhizome, the earthworm, the rosa amara, the pomegranate rind, the adenophora tetraphylla, the angelica, the phellodendron, the amethyst, the radix puerariae, the red paeony root, the epimedium herb and the dandelion root in parts by weight, and sieving the crushed materials by a 40-mesh sieve to obtain raw material particles with the particle size of less than 40 meshes;
(2) putting the raw material particles obtained in the step (1) into 3 times of water, soaking for 1 hour, then decocting for 1.5 hours to obtain a primary filtrate and filter residue, adding 2 times of water into the filter residue, soaking for 1 hour to obtain a secondary filtrate, combining the primary filtrate and the secondary filtrate, and concentrating under reduced pressure to obtain an extract with the relative density of 1.15;
(3) crushing the calcined oyster and the human placenta in parts by weight, sieving the crushed oyster and the human placenta with a 100-mesh sieve, sterilizing, adding the crushed oyster and the human placenta into the extract obtained in the step (2), and uniformly stirring and mixing to obtain a mixed paste;
(4) adding auxiliary dextrin and sucrose into the mixed paste obtained in the step (3), wherein the adding weight ratio of the mixed paste to the auxiliary dextrin to the sucrose is 10:2:1.0, uniformly stirring, granulating, and drying to obtain the compound traditional Chinese medicine for preventing and treating osteoporosis.
Example 2
Compound traditional Chinese medicine for preventing and treating osteoporosis and preparation method thereof
The formula of the compound traditional Chinese medicine for preventing and treating the osteoporosis comprises the following raw materials in parts by weight: 10 parts of drynaria rhizome, 6 parts of human placenta, 0.12 part of earthworm, 5.5 parts of bitter rose, 3.8 parts of calcined oyster shell, 6.5 parts of pomegranate rind, 6.5 parts of adenophora tetraphylla, 12 parts of angelica, 3.6 parts of phellodendron, 0.55 part of amethyst, 1.2 parts of kudzu root, 1.5 parts of red peony root, 8.5 parts of epimedium and 6.5 parts of dandelion root; the bitter rose is dried bitter rose with water content of 10 wt% in Yongdeng county of Gansu province; the preparation method of the calcined oyster comprises the following steps: cleaning 100 parts of raw oyster shells, soaking in 120 parts of rice vinegar at 40 ℃ for 20 hours, boiling to remove the rice vinegar, drying in a drying oven at 400 ℃ for 70 minutes, and crushing to obtain calcined oysters with the particle size of less than or equal to 1500 meshes; the rice vinegar is selected from glutinous rice vinegar.
The preparation method of the compound traditional Chinese medicine for preventing and treating osteoporosis comprises the following steps:
(1) crushing the drynaria rhizome, the earthworm, the rosa amara, the pomegranate rind, the adenophora tetraphylla, the angelica, the phellodendron, the amethyst, the radix puerariae, the red paeony root, the epimedium herb and the dandelion root in parts by weight, and sieving the crushed materials by a 40-mesh sieve to obtain raw material particles with the particle size of less than 40 meshes;
(2) putting the raw material particles obtained in the step (1) into water of which the weight is 7 times that of the raw material particles, soaking for 1 hour, then decocting for 3 hours to obtain primary filtrate and filter residue, adding water of which the weight is 4 times that of the filter residue, soaking and decocting for 2 hours to obtain secondary filtrate, combining the primary filtrate and the secondary filtrate, and concentrating under reduced pressure to obtain an extract with the relative density of 1.3;
(3) crushing the calcined oyster and the human placenta in parts by weight, sieving the crushed oyster and the human placenta with a 100-mesh sieve, sterilizing, adding the crushed oyster and the human placenta into the extract obtained in the step (2), and uniformly stirring and mixing to obtain a mixed paste;
(4) adding auxiliary dextrin and sucrose into the mixed paste obtained in the step (3), wherein the adding weight ratio of the mixed paste to the auxiliary dextrin to the sucrose is 10:3.5:2, uniformly stirring, granulating, and drying to obtain the compound traditional Chinese medicine for preventing and treating osteoporosis.
Example 3
Compound traditional Chinese medicine for preventing and treating osteoporosis and preparation method thereof
The formula of the compound traditional Chinese medicine for preventing and treating the osteoporosis comprises the following raw materials in parts by weight: 5 parts of drynaria rhizome, 4.5 parts of human placenta, 0.08 part of earthworm, 3 parts of bitter rose, 2.0 parts of calcined oyster shell, 3.5 parts of pomegranate rind, 3.5 parts of adenophora tetraphylla, 6 parts of angelica, 1.8 parts of phellodendron, 0.35 part of amethyst, 0.6 part of kudzu root, 0.5 part of red peony root, 5.5 parts of epimedium and 3.5 parts of dandelion root; the above bitter rose is dried bitter rose with water content of 4 wt% in Yongdeng county of Gansu province; the preparation method of the calcined oyster comprises the following steps: cleaning 100 parts of raw oyster shells, soaking the oyster shells in 90 parts of rice vinegar at 30 ℃ for 12 hours, boiling and steaming the rice vinegar, drying the rice vinegar in an oven at 340 ℃ for 55 minutes, and crushing to obtain calcined oysters with the particle size of less than or equal to 1500 meshes; the rice vinegar is fruit vinegar.
The preparation method of the compound traditional Chinese medicine for preventing and treating osteoporosis comprises the following steps:
(1) crushing the drynaria rhizome, the earthworm, the rosa amara, the pomegranate rind, the adenophora tetraphylla, the angelica, the phellodendron, the amethyst, the radix puerariae, the red paeony root, the epimedium herb and the dandelion root in parts by weight, and sieving the crushed materials by a 40-mesh sieve to obtain raw material particles with the particle size of less than 40 meshes;
(2) putting the raw material particles obtained in the step (1) into 4 times of water, soaking for 1 hour, then decocting for 2 hours to obtain a primary filtrate and filter residue, adding 2.5 times of water into the filter residue, soaking for 1.5 hours to obtain a secondary filtrate, combining the primary filtrate and the secondary filtrate, and concentrating under reduced pressure to obtain an extract with the relative density of 1.2;
(3) crushing the calcined oyster and the human placenta in parts by weight, sieving the crushed oyster and the human placenta with a 100-mesh sieve, sterilizing, adding the crushed oyster and the human placenta into the extract obtained in the step (2), and uniformly stirring and mixing to obtain a mixed paste;
(4) adding auxiliary dextrin and sucrose into the mixed paste obtained in the step (3), wherein the adding weight ratio of the mixed paste to the auxiliary dextrin to the sucrose is 10:2.5: 1.2, uniformly stirring, granulating, and drying to obtain the compound traditional Chinese medicine for preventing and treating osteoporosis.
Example 4
Compound traditional Chinese medicine for preventing and treating osteoporosis and preparation method thereof
The formula of the compound traditional Chinese medicine for preventing and treating the osteoporosis comprises the following raw materials in parts by weight: 8 parts of drynaria rhizome, 5.5 parts of human placenta, 0.10 part of earthworm, 4.5 parts of bitter rose, 3.0 parts of calcined oyster shell, 5.5 parts of pomegranate rind, 5.5 parts of radix pseudostellariae, 10 parts of angelica, 3.0 parts of phellodendron, 0.45 part of amethyst, 1.0 part of kudzu root, 1.2 parts of red paeony root, 7.0 parts of epimedium herb and 5.0 parts of dandelion root; the bitter rose is dried bitter rose with water content of 8 wt% in Yongdeng county of Gansu province; the preparation method of the calcined oyster comprises the following steps: cleaning 100 parts of raw oyster shells, soaking in 140 parts of rice vinegar at 35 ℃ for 18 hours, boiling to remove the rice vinegar, drying in a 380 ℃ oven for 65 minutes, and crushing to obtain calcined oysters with the particle size of less than or equal to 1500 meshes; the rice vinegar is selected from white rice vinegar.
The preparation method of the compound traditional Chinese medicine for preventing and treating osteoporosis comprises the following steps:
(1) crushing the drynaria rhizome, the earthworm, the rosa amara, the pomegranate rind, the adenophora tetraphylla, the angelica, the phellodendron, the amethyst, the radix puerariae, the red paeony root, the epimedium herb and the dandelion root in parts by weight, and sieving the crushed materials by a 40-mesh sieve to obtain raw material particles with the particle size of less than 40 meshes;
(2) putting the raw material particles obtained in the step (1) into 6 times of water, soaking for 1 hour, then decocting for 2.5 hours to obtain a primary filtrate and filter residue, adding 3.5 times of water into the filter residue, soaking and decocting for 2 hours to obtain a secondary filtrate, combining the primary filtrate and the secondary filtrate, and concentrating under reduced pressure to obtain an extract with the relative density of 1.25;
(3) crushing the calcined oyster and the human placenta in parts by weight, sieving the crushed oyster and the human placenta with a 100-mesh sieve, sterilizing, adding the crushed oyster and the human placenta into the extract obtained in the step (2), and uniformly stirring and mixing to obtain a mixed paste;
(4) adding auxiliary dextrin and sucrose into the mixed paste obtained in the step (3), wherein the adding weight ratio of the mixed paste to the auxiliary dextrin to the sucrose is 10:3.0:1.8, uniformly stirring, granulating, and drying to obtain the compound traditional Chinese medicine for preventing and treating osteoporosis.
Example 5
Compound traditional Chinese medicine for preventing and treating osteoporosis and preparation method thereof
The formula of the compound traditional Chinese medicine for preventing and treating the osteoporosis comprises the following raw materials in parts by weight: 7 parts of drynaria rhizome, 4.5 parts of human placenta, 0.09 part of earthworm, 3.5 parts of bitter rose, 2.5 parts of calcined oyster shell, 4.5 parts of pomegranate rind, 4.5 parts of radix pseudostellariae, 8 parts of angelica, 2.4 parts of phellodendron, 0.35 part of amethyst, 0.8 part of kudzu root, 0.9 part of red peony root, 6.0 parts of epimedium herb and 4.2 parts of dandelion root; the bitter rose is dried bitter rose with water content of 7 wt% in Yongdeng county of Gansu province; the preparation method of the calcined oyster comprises the following steps: cleaning 100 parts of raw oyster shells, soaking the oyster shells in 100 parts of rice vinegar for 15 hours at 30 ℃, boiling and steaming the rice vinegar, drying the oyster shells in a 360 ℃ oven for 60 minutes, and crushing the oyster shells to obtain calcined oysters with the particle size of less than or equal to 1500 meshes; the rice vinegar is brown rice vinegar.
The preparation method of the compound traditional Chinese medicine for preventing and treating osteoporosis comprises the following steps:
(1) crushing the drynaria rhizome, the earthworm, the rosa amara, the pomegranate rind, the adenophora tetraphylla, the angelica, the phellodendron, the amethyst, the radix puerariae, the red paeony root, the epimedium herb and the dandelion root in parts by weight, and sieving the crushed materials by a 40-mesh sieve to obtain raw material particles with the particle size of less than 40 meshes;
(2) putting the raw material particles obtained in the step (1) into water of which the weight is 5 times that of the raw material particles, soaking for 1 hour, then decocting for 2 hours to obtain primary filtrate and filter residue, adding water of which the weight is 3 times that of the filter residue, soaking and decocting for 1.5 hours to obtain secondary filtrate, combining the primary filtrate and the secondary filtrate, and concentrating under reduced pressure to obtain an extract with the relative density of 1.2;
(3) crushing the calcined oyster and the human placenta in parts by weight, sieving the crushed oyster and the human placenta with a 100-mesh sieve, sterilizing, adding the crushed oyster and the human placenta into the extract obtained in the step (2), and uniformly stirring and mixing to obtain a mixed paste;
(4) and (4) adding auxiliary dextrin and sucrose into the mixed paste obtained in the step (3), wherein the adding weight ratio of the mixed paste to the auxiliary dextrin to the sucrose is 10:2.5:1.5, granulating after uniformly stirring, and drying to obtain the compound traditional Chinese medicine for preventing and treating osteoporosis.
Test examples
1. General data
1) Test group a: 100 patients with age of 45-54 years have obvious osteoporosis clinical symptoms after menopause, and the affected parts comprise cervical vertebra, lumbar vertebra, knee joint and naked joint and are confirmed by clinicians. 100 patients were randomized into trial a1 group 50 and control a2 group 50.
2) Test group b: 50 people are 42-49 years old, have no obvious osteoporosis clinical symptoms after amenorrhea is finished, but have obvious emotion and other body reactions after amenorrhea.
2. Method of administration
The calcium carbonate chewable tablets are taken by the test a1 group and the control a2 group twice a day, 1 tablet each time, and the compound traditional Chinese medicine for preventing and treating osteoporosis, prepared by the embodiment 5, is further taken by the test a1 group of patients twice a day, 2 tablets each time, 30 days as a treatment course, and 2 treatment courses are continuously taken.
Patients in test group b took the compound traditional Chinese medicine for preventing and treating osteoporosis prepared in embodiment 5 of the invention singly twice a day, 2 granules each time, 30 days as a treatment course, and continuously took 2 treatment courses.
3. Criteria for efficacy assessment
1) Diagnostic criteria
Is made according to the flat-top requirement of the clinical research guiding principle of the new traditional Chinese medicine for treating the osteoporosis in the clinical research guiding principle of the new traditional Chinese medicine. The performance includes: soreness and weakness of waist and knees, walking difficulty, dizziness, vertigo, inability to hold the weight, reddish or pale tongue, thin or white tongue coating, deep and thready pulse, and osteoporosis.
2) Flat top standard of therapeutic effect
And (3) curing: clinical symptoms and physical signs disappear, the function returns to normal, and the disease does not relapse for more than one year
The effect is shown: the clinical symptoms and physical signs are obviously relieved, and the function is basically recovered to be normal
The method has the following advantages: partial reduction of clinical symptoms and signs
And (4) invalidation: the treatment is continued for more than one course of treatment, and the symptoms and physical signs are not changed.
4. Therapeutic results
The therapeutic effect of the patients in test group a is shown in table 1.
| Group of | The number of people cured | Number of effective people | Number of effective persons | Number of invalid persons | Total effective rate |
| Test a1 group | 21 persons | 13 persons | 12 persons | 4 persons | 92％ |
| Test a2 group | 18 persons | 10 persons | 10 persons | 12 persons | 76％ |
In the test group b, no osteoporosis symptom appears in 44 patients and slight osteoporosis symptom appears in 6 patients within 2-5 years after two treatment courses of medicine.
The above description is only a preferred embodiment of the present invention, and is not intended to limit the present invention, and various modifications and changes may be made to the embodiment of the present invention by those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (9)
1. The compound traditional Chinese medicine for preventing and treating osteoporosis is characterized in that the formula of the compound traditional Chinese medicine for preventing and treating osteoporosis comprises the following raw materials in parts by weight: 4 to 10 parts of drynaria rhizome, 3 to 6 parts of human placenta, 0.06 to 0.12 part of earthworm, 2 to 5.5 parts of bitter rose, 1.3 to 3.8 parts of calcined oyster shell, 2.5 to 6.5 parts of pomegranate bark, 2.5 to 6.5 parts of radix pseudostellariae, 4 to 12 parts of angelica, 1.2 to 3.6 parts of phellodendron, 0.2 to 0.55 part of amethyst, 0.4 to 1.2 parts of kudzu root, 0.3 to 1.5 parts of red paeony root, 4 to 8.5 parts of epimedium herb and 2 to 6.5 parts of dandelion root.
2. The compound traditional Chinese medicine for preventing and treating osteoporosis of claim 1, wherein the formula of the compound traditional Chinese medicine for preventing and treating osteoporosis comprises the following raw materials in parts by weight: 5 to 8 parts of drynaria rhizome, 4.5 to 5.5 parts of human placenta, 0.08 to 0.10 part of earthworm, 3 to 4.5 parts of bitter rose, 2.0 to 3.0 parts of calcined oyster, 3.5 to 5.5 parts of pomegranate peel, 3.5 to 5.5 parts of rhizoma gastrodiae, 6 to 10 parts of angelica, 1.8 to 3.0 parts of phellodendron, 0.35 to 0.45 part of amethyst, 0.6 to 1.0 part of kudzu root, 0.5 to 1.2 parts of red paeony root, 5.5 to 7.0 parts of epimedium herb and 3.5 to 5.0 parts of dandelion root.
3. The compound traditional Chinese medicine for preventing and treating osteoporosis of claim 1, wherein the formula of the compound traditional Chinese medicine for preventing and treating osteoporosis comprises the following raw materials in parts by weight: 7 parts of drynaria rhizome, 4.5 parts of human placenta, 0.09 part of earthworm, 3.5 parts of bitter rose, 2.5 parts of calcined oyster shell, 4.5 parts of pomegranate rind, 4.5 parts of radix pseudostellariae, 8 parts of angelica, 2.4 parts of phellodendron, 0.35 part of amethyst, 0.8 part of kudzu root, 0.9 part of red peony root, 6.0 parts of epimedium herb and 4.2 parts of dandelion root.
4. The compound traditional Chinese medicine for preventing and treating osteoporosis of claim 1, wherein the rosa laevigata is dried rosa laevigata of Yongdeng county, Gansu province with a water content of 4-10 wt%.
5. The compound traditional Chinese medicine for preventing and treating osteoporosis of claim 1, wherein the preparation method of the calcined oyster comprises the following steps: cleaning 100 parts of raw oyster shells, soaking in 80-120 parts of rice vinegar at 25-40 ℃ for 10-20 hours, boiling to remove the rice vinegar, drying in an oven at 320-400 ℃ for 50-70 minutes, and crushing to obtain calcined oysters.
6. The compound traditional Chinese medicine for preventing and treating osteoporosis as claimed in claim 5, wherein the rice vinegar is selected from any one of brown rice vinegar, glutinous rice vinegar, fruit vinegar and white rice vinegar.
7. The compound traditional Chinese medicine for preventing and treating osteoporosis of claim 5, wherein the particle size of the calcined oyster obtained by crushing is less than or equal to 1500 meshes.
8. The preparation method of the compound traditional Chinese medicine for preventing and treating osteoporosis as claimed in any one of claims 1 to 7, comprising the following steps:
(1) crushing the drynaria rhizome, the earthworm, the rosa amara, the pomegranate rind, the adenophora tetraphylla, the angelica, the phellodendron, the amethyst, the radix puerariae, the red paeony root, the epimedium herb and the dandelion root in parts by weight, and sieving the crushed materials by a 40-mesh sieve to obtain raw material particles with the particle size of less than 40 meshes;
(2) putting the raw material particles obtained in the step (1) into water of which the weight is 3-7 times that of the raw material particles, soaking for 1 hour, decocting for 1.5-3 hours to obtain primary filtrate and filter residue, adding water of which the weight is 2-4 times that of the filter residue, soaking for 1-2 hours to obtain secondary filtrate, combining the primary filtrate and the secondary filtrate, and concentrating under reduced pressure to obtain an extract with the relative density of 1.15-1.3;
(3) crushing the calcined oyster and the human placenta in parts by weight, sieving the crushed oyster and the human placenta with a 100-mesh sieve, sterilizing, adding the crushed oyster and the human placenta into the extract obtained in the step (2), and uniformly stirring and mixing to obtain a mixed paste;
(4) and (4) adding auxiliary dextrin and cane sugar into the mixed paste obtained in the step (3), uniformly stirring, granulating, and drying to obtain the compound traditional Chinese medicine for preventing and treating osteoporosis.
9. The preparation method of the compound traditional Chinese medicine for preventing and treating osteoporosis of claim 8, wherein in the step (4), the weight ratio of the mixed paste to the auxiliary dextrin to the sucrose is 10: 2-3.5: 1.0-2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210071537.1A CN114522196B (en) | 2022-01-21 | 2022-01-21 | Compound traditional Chinese medicine for preventing and treating osteoporosis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210071537.1A CN114522196B (en) | 2022-01-21 | 2022-01-21 | Compound traditional Chinese medicine for preventing and treating osteoporosis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114522196A true CN114522196A (en) | 2022-05-24 |
| CN114522196B CN114522196B (en) | 2022-08-26 |
Family
ID=81620283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210071537.1A Expired - Fee Related CN114522196B (en) | 2022-01-21 | 2022-01-21 | Compound traditional Chinese medicine for preventing and treating osteoporosis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114522196B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181488A (en) * | 2007-11-28 | 2008-05-21 | 于世鹏 | Chinese medicine composition orally taken for curing osteosporosis |
| CN101856114A (en) * | 2010-05-14 | 2010-10-13 | 浙江省医学科学院 | Health food with bone intensity enhancing function and preparation method thereof |
| CN104095914A (en) * | 2013-04-02 | 2014-10-15 | 上海圣赐康生物医药科技有限公司 | Bone-peaceful capsule formula increasing bone mineral density and preparation method thereof |
-
2022
- 2022-01-21 CN CN202210071537.1A patent/CN114522196B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181488A (en) * | 2007-11-28 | 2008-05-21 | 于世鹏 | Chinese medicine composition orally taken for curing osteosporosis |
| CN101856114A (en) * | 2010-05-14 | 2010-10-13 | 浙江省医学科学院 | Health food with bone intensity enhancing function and preparation method thereof |
| CN104095914A (en) * | 2013-04-02 | 2014-10-15 | 上海圣赐康生物医药科技有限公司 | Bone-peaceful capsule formula increasing bone mineral density and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 宁钻: ""补肾活血汤治疗原发性骨质疏松症40例"", 《河南中医》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114522196B (en) | 2022-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327390B (en) | Formula for Chinese medicine for preventing and treating chemotherapeutic toxic and side reaction and preparation method for Chinese medicinal pills | |
| CN101015651A (en) | Medicine for treating protrusion of lumbar intervertebral disc | |
| CN101537093A (en) | Chinese traditional medicine for preventing and curing osteoporosis and preparation method thereof | |
| CN111298019B (en) | Traditional Chinese medicine for treating tachyarrhythmia | |
| CN106728770B (en) | Traditional Chinese medicine composition for tonifying kidney and replenishing vital essence and preparation method thereof | |
| CN104491778A (en) | Pharmaceutical composition for treating alopecia areata | |
| CN114522196B (en) | Compound traditional Chinese medicine for preventing and treating osteoporosis and preparation method thereof | |
| CN103751301B (en) | For the goods of aseptic necrosis of femoral head patient | |
| CN109381627B (en) | Medicine for treating uremia and preparation method thereof | |
| CN108785421B (en) | A Chinese medicinal composition for treating fracture and its preparation method | |
| CN106266204A (en) | One treats osteoporotic medicine | |
| CN102743550B (en) | Medicine composition for accelerating healing after fracture surgery, preparation method and application | |
| CN114306549B (en) | Traditional Chinese medicine composition for improving joint movement function after hip replacement surgery and relieving postoperative pain, preparation and application | |
| CN102949601B (en) | Medicine for treating alopecia areata and preparation method thereof | |
| CN114886983B (en) | Traditional Chinese medicine composition for improving polycystic ovarian syndrome and preparation method thereof | |
| CN115645484B (en) | Traditional Chinese medicine composition for treating bone fracture diseases and preparation method, preparation and application thereof | |
| CN111568986B (en) | Chinese medicinal oral prescription for setting fracture, external ointment and preparation method thereof | |
| CN111388564B (en) | Traditional Chinese medicine for treating bradyarrhythmia | |
| CN1241587C (en) | Chinese medicinal preparation for treating gynopathy | |
| CN105748887A (en) | Traditional Chinese medicine composition for treating insomnia and preparation method of traditional Chinese medicine composition | |
| CN105412244A (en) | Traditional Chinese medicine composition treating gynecological cervicitis | |
| CN106237249A (en) | A kind of Chinese medicinal capsule for treating Women’s climacteric insomnia | |
| CN105213793A (en) | Cure mainly osteoporotic Chinese medicine composition and method for making | |
| CN1115162C (en) | Pure traditional Chinese medicine for treating hyperosteogeny and preparation process thereof | |
| CN105194469A (en) | Traditional Chinese medicine oral liquid for treating psoriasis and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20220826 |